These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6337063)

  • 1. Multiple serotonin receptors and their physiological significance.
    Peroutka SJ; Snyder SH
    Fed Proc; 1983 Feb; 42(2):213-7. PubMed ID: 6337063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
    Peroutka SJ; Snyder SH
    Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors.
    Cohen ML; Colbert WE
    J Pharmacol Exp Ther; 1986 Jun; 237(3):713-8. PubMed ID: 3712277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline.
    Peroutka SJ; Snyder SH
    J Pharmacol Exp Ther; 1980 Dec; 215(3):582-7. PubMed ID: 6255132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro.
    Leysen JE
    J Physiol (Paris); 1981; 77(2-3):351-62. PubMed ID: 7288650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.
    Friedman RL; Barrett RJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1984 Mar; 228(3):628-35. PubMed ID: 6707913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of serotonin receptors.
    Göthert M; Schlicker E
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S3-7. PubMed ID: 2446065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A
    Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
    Lucki I; Nobler MS; Frazer A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
    Monsma FJ; Shen Y; Ward RP; Hamblin MW; Sibley DR
    Mol Pharmacol; 1993 Mar; 43(3):320-7. PubMed ID: 7680751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats.
    Marona-Lewicka D; Kurrasch-Orbaugh DM; Selken JR; Cumbay MG; Lisnicchia JG; Nichols DE
    Psychopharmacology (Berl); 2002 Oct; 164(1):93-107. PubMed ID: 12373423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase.
    Plassat JL; Amlaiky N; Hen R
    Mol Pharmacol; 1993 Aug; 44(2):229-36. PubMed ID: 8394987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic profile of amphetamine derivatives at various brain recognition sites: selective effects on serotonergic systems.
    Battaglia G; De Souza EB
    NIDA Res Monogr; 1989; 94():240-58. PubMed ID: 2514364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative autoradiographic mapping of serotonin 5-HT1 and 5-HT2 receptors and uptake sites in the neocortex of the rhesus monkey.
    Lidow MS; Goldman-Rakic PS; Gallager DW; Rakic P
    J Comp Neurol; 1989 Feb; 280(1):27-42. PubMed ID: 2918094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors.
    Choudhary MS; Craigo S; Roth BL
    Mol Pharmacol; 1992 Oct; 42(4):627-33. PubMed ID: 1435740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-second schedule.
    Marek GJ; Li AA; Seiden LS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):52-9. PubMed ID: 2746510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of the medullary serotonergic system in the piglet.
    Niblock MM; Kinney HC; Luce CJ; Belliveau RA; Filiano JJ
    Auton Neurosci; 2004 Feb; 110(2):65-80. PubMed ID: 15046730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.
    Kilpatrick GJ; Jones BJ; Tyers MB
    Nature; 1987 Dec 24-31; 330(6150):746-8. PubMed ID: 3696238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of selective and nonselective compounds for the 5-HT 1A and 5-HT 1B receptor subtypes in rat frontal cortex.
    Sills MA; Wolfe BB; Frazer A
    J Pharmacol Exp Ther; 1984 Dec; 231(3):480-7. PubMed ID: 6502510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.